Tang Capital Management’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11,065,662	Closed	-$35.3M	–	107
2025 Q3	$35.3M	Hold	11,065,662	–	–	1.36%	21
2025 Q2	$25.1M	Buy	11,065,662 +4,347,837	+65%	+$7.01M	1.27%	23
2025 Q1	$4.27M	Sell	6,717,825 -593,935	-8%	-$461K	0.24%	78
2024 Q4	$7.53M	Sell	7,311,760 -500,000	-6%	-$538K	0.5%	56
2024 Q3	$9.22M	Buy	7,811,760 +19,824	+0.3%	+$25.2K	0.66%	45
2024 Q2	$9.51M	Buy	7,791,936 +1,341,936	+21%	+$2.67M	0.97%	34
2024 Q1	$14.1M	Sell	6,450,000 -100,000	-2%	-$185K	1.46%	22
2023 Q4	$10.2M	Buy	6,550,000 +100,000	+2%	+$131K	0.94%	29
2023 Q3	$8.32M	Sell	6,450,000 -150,000	-2%	-$236K	1.17%	28
2023 Q2	$11.4M	Buy	6,600,000 +506,968	+8%	+$842K	1.67%	19
2023 Q1	$9.2M	Buy	6,093,032 +2,582,587	+74%	+$5.84M	1.37%	27
2022 Q4	$5.62M	Buy	3,510,445 +10,445	+0.3%	+$15.5K	0.82%	32
2022 Q3	$5.08M	Buy	3,500,000 +2,445,327	+232%	+$3.76M	0.62%	42
2022 Q2	$1.93M	Buy	+1,054,673	New	+$2.02M	0.29%	51
2022 Q1	–	Sell	-152,345	Closed	-$660K	–	54
2021 Q4	$660K	Buy	+152,345	New	+$892K	0.13%	29
2020 Q4	–	Sell	-112,880	Closed	-$751K	–	13
2020 Q3	$751K	Sell	112,880 -187,120	-62%	-$1.39M	0.14%	19
2020 Q2	$2.5M	Hold	300,000	–	–	0.24%	17
2020 Q1	$2.3M	Buy	+300,000	New	+$2.09M	0.32%	19

Other funds holding CTMX